ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Other Non-Cash Items

Other non-cash adjustments that reconcile net income to operating cash flow.

No reported Other Non-Cash Items figures are available to summarize.

Other Non-Cash Items history

Currency unavailable · from the cash flow

No Other Non-Cash Items data reported for this period type.

Other Non-Cash Items vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Other Non-Cash Items for ADRX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MGTXMeiraGTx Holdings plcLTM Mar 2026$179.4M USD+22894.9%-19.7%224.9%
SLNSilence Therapeutics plcLTM Mar 2026$70.22M USD——7620.1%
BNTCBenitec Biopharma Inc.LTM Mar 2026$13.59M USD+536.4%——
STOKStoke Therapeutics, Inc.LTM Mar 2026$9.75M USD+360.5%+6.0%30.4%
WVEWave Life Sciences Ltd.LTM Mar 2026$9.43M USD—+1176.7%13.1%
PRMEPrime Medicine, Inc.LTM Mar 2026$8.21M USD-29.9%-19.4%203.5%
PRQRProQR Therapeutics N.V.LTM Mar 2026€3.3M EUR+368.6%—24.5%
ARCTArcturus Therapeutics Holdings Inc.LTM Mar 2026$2.66M USD+505.4%-9.4%5.9%
RNAAtrium Therapeutics, Inc.FY2025$712K USD——3.8%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —+437.0%-9.4%27.5%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.